XML 27 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2011
Dec. 31, 2010
Dec. 31, 2010
Technology rights
Dec. 31, 2010
Patents, net
Dec. 31, 2010
Website development
Sep. 30, 2010
Restated Amount
Dec. 31, 2009
Restated Amount
Dec. 31, 2009
Restated Amount
Technology rights
Dec. 31, 2009
Restated Amount
Patents, net
Dec. 31, 2009
Restated Amount
Website development
Dec. 31, 2009
Restated Amount
Patent pending technology
Dec. 31, 2009
Restated Amount
Customer List
CASH FLOWS FROM OPERATING ACTIVITIES:                        
Net profit (loss) $ 110,089 $ (7,015,896)       $ (3,372,295) $ (16,032,756)          
Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities:                        
Stock, warrants, options and notes issued for compensation and services 183,532 144,912       69,734 686,237          
Non-cash interest expense, including amortization of beneficial conversion value, warrant related debt discounts and intrinsic value of convertible debt and amortization of debt discount and amortization of debt offering costs 316,414 3,859,342       3,668,122 3,096,641          
Non-cash (profit) loss on equity method investment (21,457) (78,074)       (50,796) 41,424          
Bad debt expense 77,449 64,684       27,954 114,197          
Amortization     262,788 17,415 10,733     238,998 18,443 14,311    
Impairment of Intangible assets     3,105,956 418,185         136,811   210,403 246,237
Impairment of goodwill             10,241,529          
Inventory reserve 135,995 64,005       38,530            
Loss on disposal of assets   6,336                    
Net profit (loss) - noncontrolling interest 67,872 (444,620)       (38,686) (10,791)          
Depreciation 403,866 432,974       341,079 396,302          
Amortization   769       833 578          
(Increase) decrease in assets:                        
Trade accounts receivable (304,420) (705,556)       (315,233) (474,876)          
Other accounts receivable (26,186) (8,074)       (13,762) 103,100          
Other accounts receivable, related party 2,433 (13,628)       (6,636) 6,194          
Notes receivable             (275,000)          
Inventory (427,940) (1,092,696)       (855,008) 1,375,660          
Prepaid expenses and other current assets 26,526 23,924       115,159 (119,489)          
Investments - long term                          
Deposits and other assets 59,215 (28,215)       34,483 5,411          
Increase (decrease) in liabilities:                        
Accounts payable 216,108 219,016       123,173 427,834          
Accrued expenses (462,933) 1,023,001       1,180,098 463,869          
Accrued compensation (289,067) 163,876       64,208 (535,488)          
Unearned revenue (4,407) (14,408)       4,097 84,438          
NET CASH PROVIDED BY (USED IN) CONTINUING OPERATING ACTIVITIES 264,625 416,749       1,223,268 460,217          
NET CASH PROVIDED BY (USED IN) DISCONTINUED OPERATING ACTIVITIES 22,141 78,295       (805,557) (95,530)          
CASH FLOWS FROM INVESTING ACTIVITIES:                        
Cash (paid) at acquisition, net of cash received             (29,440)          
Investment in intangible assets     (70,000) (7,230)       (182,441) (25,355)      
Proceeds from Notes receivable 47,333 60,376       45,005 317,313          
Payments from Notes receivable                          
Purchase of property and equipment (343,086) (352,345)       (329,068) (240,455)          
NET CASH (USED IN) CONTINUING INVESTING ACTIVITIES (339,817) (369,199)       (361,293) (160,378)          
NET CASH PROVIDED BY (USED IN) DISCONTINUED INVESTING ACTIVITIES 195,278 (36,096)       (40,639) (69,592)          
CASH FLOWS FROM FINANCING ACTIVITIES:                        
Proceeds from (payments to) demand notes payable, net of debt offering costs 673,652 (772,450)       (290,834) 672,245          
Proceeds from (payments to) notes and loans payable (58,531) (2,289,413)       (2,092,843) (632,757)          
Payments on notes and loans payable, related party (487,208) (1,077,738)       (177,738) (246,596)          
Proceeds from conversion of debt to non-controlling interest   66,667       66,667            
Proceeds from convertible note payable, related party 35,000                      
Proceeds from sales of common stock, and exercise of warrants and options, net of offering costs 50,000 3,450,218       2,017,718 9,808          
NET CASH PROVIDED BY (USED IN) CONTINUING FINANCING ACTIVITIES 212,913 (622,716)       (477,030) (197,300)          
NET CASH PROVIDED BY (USED IN) DISCONTINUED FINANCING ACTIVITIES (648,218) 537,921       552,705 (116,938)          
EFFECT OF EXCHANGE RATE CHANGES ON CASH 63,005 (22,617)       (23,849) (28,193)          
Cash and cash equivalents at beginning of year 373,823 391,486       391,486 599,200          
Cash and cash equivalents at end of period 143,750 373,823       459,091 391,486          
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (230,073) (17,663)       67,605 (207,714)          
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:                        
Income taxes paid 35,280                      
Interest paid 693,884 966,097       775,175 869,597          
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:                        
Note receivable, related party applied to note payable, related party 192,508                      
Discount on debt for intrinsic value of convertible notes payable   3,143,071         2,415,093          
Amortization of debt offering costs   716,271         681,548          
Conversion of debt to common stock   1,620,000       242,559            
Conversion of accrued liabilities to common stock   242,559       1,320,000            
Common stock issued for consulting services and compensation and accrued liabilities payable in common stock 42,000 70,000       42,000 548,170          
Forgiveness of debt treated as capital contribution           $ 7,943,292